Back | Next |
home / stock / gild / gild message board
Subject | By | Source | When |
---|---|---|---|
Gilead Sciences Inc ($GILD) | mick | investorshub | 03/12/2022 8:03:28 PM |
Gilead Sciences Inc ($GILD) | mick | investorshub | 02/15/2022 9:33:38 PM |
Gilead Sciences Inc ($GILD) | mick | investorshub | 02/06/2022 10:27:48 PM |
$GILD owes ViiV* $1.25B+ 3% royalty on US Biktarvy sales, | DewDiligence | investorshub | 02/02/2022 12:04:10 AM |
$GILD 4Q21 results | DewDiligence | investorshub | 02/01/2022 9:08:45 PM |
https://www.otcmarkets.com/stock/$GILD | mick | investorshub | 01/02/2022 11:12:00 PM |
GILD vs $BMY in LBCL$ CAR-Twho has the edge? | DewDiligence | investorshub | 12/14/2021 12:04:16 AM |
https://www.otcmarkets.com/stock/$GILD | mick | investorshub | 12/12/2021 12:17:35 AM |
$GILD and$ MTNB have been working on ORAL | dhbuzz | investorshub | 12/09/2021 4:13:41 PM |
VIR/$GILD start phase-2 trial testing quadruple regimen of | DewDiligence | investorshub | 12/09/2021 3:06:27 PM |
I Agree: https://www.griproom.com/fun/pfizers-covid-pill-might-not-be-as-great-a | Michel | investorshub | 11/08/2021 12:09:56 PM |
Showtime this week! Brilacidin is a BEAST. Remdesivir | Ultimate01 | investorshub | 11/08/2021 12:05:18 PM |
Gilead Sciences Inc ($GILD) | mick | investorshub | 11/07/2021 5:27:25 PM |
i think so they got ah good pipeline though | mick | investorshub | 11/07/2021 5:27:17 PM |
http://www.ipharminc.com/press-release/2020/9/15/laboratory-testing-of-brilacidi | Michel | investorshub | 11/02/2021 11:33:38 AM |
Mick, I think we are the only ones | slimhere | investorshub | 10/29/2021 2:36:58 PM |
$15 under wow | mick | investorshub | 10/28/2021 9:11:11 PM |
Gilead Sciences Inc ($GILD) | mick | investorshub | 10/28/2021 9:10:40 PM |
5PM, we'll see how close you are, I'm | slimhere | investorshub | 10/28/2021 7:09:44 PM |
$gild should be over $80 to $100 imho | mick | investorshub | 10/10/2021 4:18:04 PM |
News, Short Squeeze, Breakout and More Instantly...
Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...
– Additional Data in Pregnant Adults Who Are Virologically Suppressed Reinforce Safety and Tolerability Profile of Biktarvy in Broad Range of People With HIV – – Perinatal Guidelines Recognize Biktarvy as Alternative Regimen for Use During Pregnancy an...